Abstract
The efficacy of nucleoside(tide) analogues (NA) in the treatment of acute liver failure due to hepatitis B virus (HBV-ALF) remains controversial. We determined retrospectively the impact of NAs in a large cohort of patients with HBV-ALF.
Original language | English |
---|---|
Journal | Digestive Diseases and Sciences |
Volume | 57 |
Issue number | 5 |
Pages (from-to) | 1349-57 |
Number of pages | 9 |
ISSN | 0163-2116 |
DOIs | |
Publication status | Published - 2012 |
Keywords
- Adult
- Aged
- Antiviral Agents
- Bilirubin
- Female
- Hepatic Encephalopathy
- Hepatitis B
- Hepatitis B virus
- Humans
- Liver Failure, Acute
- Liver Transplantation
- Male
- Middle Aged
- Nucleosides
- Prothrombin Time
- ROC Curve
- Retrospective Studies
- Severity of Illness Index
- Survival Analysis
- Transaminases
- Treatment Outcome
- Virus Replication